Overview

A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With Itraconazole

Status:
Not yet recruiting
Trial end date:
2022-04-27
Target enrollment:
Participant gender:
Summary
A study to demonstrate pharmacokinetics of AZD4831 when administered alone and in combination with Itraconazole.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel
Treatments:
Itraconazole